Navigation Links
Why some take to greens, while others don’t

Don’t blame yourself, if your taste buds get tickled at the thought of greens or simply clam up at its mere mention! A recent investigation into the reasons// for the delights and aversions to green vegetarian food has shown that such tendencies are gene-centric.

All the same, the researchers opine that, this could be the only way, the body balances the requirement of minerals and nutrients, to be in the pink of health. To understand such inclinations, researchers from the Mon-ell Chemical Sciences Center in Philadelphia sought the evaluation of volunteers with comments regarding a variety of vegetables.

According to the scientists, there exist two types of the gene, - the sensitive and insensitive. The researchers found that, those with a pair of sensitive genes did not take to greens, while those with the insensitive pair of genes, loved green vegetables. The subjects, who had both the sensitive and insensitive within a pair of genes, were midway between liking and disliking greens.

However, this research does not rule out the fact that people with extreme likes or dislikes, can over a period of time, learn to develop a taste for vegetables, especially as they age.
'"/>




Page: 1

Related medicine news :

1. Depression has a worthwhile treatment
2. Care for the elderly at home while away during the festive season
3. Mother pronounced dead while delivering twins
4. Be cautious while on the Trampoline
5. Environment while serving of alcohol no factor in reduction in Alcohol-Related Injuries
6. Doctors must exercise caution while prescribing medicines to elders
7. Come Apart and Rest Awhile – It’s Christma!
8. Allergies are related to mothers menses
9. Mothers with periodontitis may deliver premature babies
10. Changing Partners may put Expectant Mothers at Risk
11. Link Between Mothers Depression and Violence in Children
Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Why some take greens while others don

(Date:9/5/2008)...ert Pathologists Discuss the Latest Developments i...RTHFIELD, Ill., Sept. 5 /PRNewswire-USNewswire/ --...point. Molecular testing and the promise,of person...reated. Digital,slides and other imaging technolog...lege of American Pathologists is taking a leadersh...
(Date:9/5/2008)...hers explain how theoretical ,anti-cloak, could br...pt. 5 (HealthDay News) -- Just in case someone dev...cientists say they know how to uncloak the objects... Optics Express , certain materials underneath an ...o be seen again. , Researchers at Shanghai Jiao...
(Date:9/5/2008)...HINGTON, Sept. 5 /PRNewswire-USNewswire/ -- Speake...y in support of the aims of the "Stand,Up to Cance... "There is not a person in our country who has no...r kills 565,000 Americans annually, and each,year ...ricans must work,together to make eradicating the ...
(Date:9/5/2008)...HINGTON, Sept. 5 /PRNewswire-USNewswire/ -- U.S. c...r relief to Cuban victims of Hurricane,Gustav, whi...s., (http://www.PanAmericanRelief.org ), "Donatio...perately need,after this natural disaster," says M... Initiative at the Pan American Development Founda...
Breaking Medicine News(10 mins):Health News:Leaders in Pathology Meet in San Diego: Sept. 25 - 28, 2008 2Health News:Cuban Disaster Relief Donations Sought in the Wake of Hurricane Gustav 2
...nconvenient Truth" to heated Congressional debates...fuels, the issue of coal's place in supplying Amer...portance in recent months. A research institute a..., has been exploring ways to increase the efficien...
..., Western Australia, are bracing themselves for a ...ildren within a day . The fear comes after three ... fatal strain in the past 72 hours. Staff at The ...mitted its Emergency Department had been bursting ...
...recovered from the bottom of a two-kilometre thick...was much warmer at some point during the last Ice ...the trees, plants and insects of a boreal forest e...00,000 years old. Previously, the youngest evidenc...
...rsity researcher is experimenting with ways to add...we like about our favourite snacks . Sajid Alavi ...ustry at K-State's College of Agriculture. His e...ocessing, which is used to make products from chee...
Other Medicine News:Health News:An Inconvenient Truth-Coal to Liquid 2Health News:Flu Outbreak Among Children Feared in Western Australia 2Health News:Now, Fibre-enriched Tasty Snacks in the Making 2
(Date:9/4/2008)...vival Data for Ipilimumab to be Presented, PRINCE...ex, Inc.,(Nasdaq: MEDX ) announced today that nin...ional anti-CTLA-4 antibody, in melanoma are schedu... Congress of the European Society,for Medical Onco...ockholm.,Many of the following abstracts will incl...
(Date:9/4/2008)...emain on Schedule with Two Abstracts Accepted for ...in November 2008, BRIDGEWATER, N.J., Sept. 4 /PRN...ialty pharmaceutical company focused on the treatm... announced the appointment of,Peter L. Garrambone,...Garrambone,s career includes more than 50 pharmace...
(Date:9/3/2008)...t. 3 /- Simcere,Pharmaceuti...d supplier of,branded generic pharmaceuticals and ...roduct Endu (also known as Endostar) in China,ann...al study., At the request of the SFDA, Simcere in...ate the safety and therapeutic efficacy of Endu, a...
(Date:9/3/2008)... National Vascular Disease Awareness Month, CHARL... Pharmaceuticals,LLC, a clinical-stage drug-develo...eatment of unmet medical needs, announced today th... clinical trial of its lead drug,candidate trans s...00725881,on the clinicaltrials.gov Website, is inv...
Breaking Medicine Technology:Medarex Announces Presentations at the 33rd Congress of the European Society for Medical Oncology 2Medarex Announces Presentations at the 33rd Congress of the European Society for Medical Oncology 3Aegerion Pharmaceuticals, Inc. adds Peter Garrambone to Board of Directors, Secures Additional Capital for Clinical Trials 2Simcere Pharmaceutical Group Announces Interim Results of Endu Phase IV Clinical Study 2Simcere Pharmaceutical Group Announces Interim Results of Endu Phase IV Clinical Study 3Diffusion Pharmaceuticals Announces Initiation of a Phase I/II Clinical Trial in Patients with Peripheral Arterial Disease (PAD) 2Diffusion Pharmaceuticals Announces Initiation of a Phase I/II Clinical Trial in Patients with Peripheral Arterial Disease (PAD) 3Diffusion Pharmaceuticals Announces Initiation of a Phase I/II Clinical Trial in Patients with Peripheral Arterial Disease (PAD) 4Aida Pharmaceuticals Inc Announces Availability of Downloadable Corporate Synopsis on its Website 17404 1Aida Pharmaceuticals Inc Announces Availability of Downloadable Corporate Synopsis on its Website 17404 2Pathwork 28R 29 Diagnostics Launches Genomics Based Test For Hard To Identify Tumors Through Its CLIA Certified Laboratory 4765 1Pathwork 28R 29 Diagnostics Launches Genomics Based Test For Hard To Identify Tumors Through Its CLIA Certified Laboratory 4765 2Pathwork 28R 29 Diagnostics Launches Genomics Based Test For Hard To Identify Tumors Through Its CLIA Certified Laboratory 4765 3Smiths Medical to Promote and Distribute Abbotts FreeStyle Navigator Continuous Glucose Monitoring System 4761 1Smiths Medical to Promote and Distribute Abbotts FreeStyle Navigator Continuous Glucose Monitoring System 4761 2Smiths Medical to Promote and Distribute Abbotts FreeStyle Navigator Continuous Glucose Monitoring System 4761 3Smiths Medical to Promote and Distribute Abbotts FreeStyle Navigator Continuous Glucose Monitoring System 4761 4Detour 28R 29 Unveils Snack Size Protein Bar 17400 1Detour 28R 29 Unveils Snack Size Protein Bar 17400 2
...y Announces Lead Investigator for U.S. Trial -, MI.../ - YM,BioSciences Inc. , an oncology company that...iated products for patients worldwide,today annou...9,patient, randomized, placebo-controlled, multi-c...). AeroLEF(TM) is a unique,inhaled-delivery compo...
...Highlighted in Oral Presentation at International ...uly 10, 2007 /PRNewswire-FirstCall/ -- Baxter,Heal...n of findings,from the ADAPT (Analysis of Data fro...base showing a statistically significant,relations... VIII,blood levels below one international unit pe...
Other Medicine Technology:YM BioSciences Announces Secondary Efficacy and Safety Findings in,Randomized Phase IIB Aerolef Trial 2YM BioSciences Announces Secondary Efficacy and Safety Findings in,Randomized Phase IIB Aerolef Trial 3YM BioSciences Announces Secondary Efficacy and Safety Findings in,Randomized Phase IIB Aerolef Trial 4YM BioSciences Announces Secondary Efficacy and Safety Findings in,Randomized Phase IIB Aerolef Trial 5Clinical Data Suggest Decreased Bleeding Risk in People With Severe,Hemophilia A While Maintaining Factor VIII Levels Above One Percent 2Clinical Data Suggest Decreased Bleeding Risk in People With Severe,Hemophilia A While Maintaining Factor VIII Levels Above One Percent 3Clinical Data Suggest Decreased Bleeding Risk in People With Severe,Hemophilia A While Maintaining Factor VIII Levels Above One Percent 4Clinical Data Suggest Decreased Bleeding Risk in People With Severe,Hemophilia A While Maintaining Factor VIII Levels Above One Percent 5
Ties improve torso fit and transfer weight to waist and hips. Ties are 1"W cotton woven for flexibility and sewn at an angle across the full width of the two back sections for durability.
Use this workhorse apron where 360 of protection from direct and scatter radiation is required.
Mini Aprons are half aprons with an easy-on, easy-off Velcro-style closure that fastens securely in seconds. Color-coded sizes for easy identification. Offers 0.5 mm Pb equivalent protection.
...IA, a rapid and simple test for rotavirus infectio...t. The Pathfinder Rotavirus Enzyme Immunoassay Di... of rotavirus directly from patient specimens. Th...iy of monoclonal antibodies with the speed and eff...
Medicine Products: